Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Other Non-Current Liabilities (2022 - 2024)

HeartSciences filings provide 3 years of Other Non-Current Liabilities readings, the most recent being $32103.0 for Q4 2024.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $32103.0 in Q4 2024 year-over-year; TTM through Oct 2024 was $32103.0, a N/A change, with the full-year FY2023 number at $187450.0, down 19.5% from a year prior.
  • Other Non-Current Liabilities hit $32103.0 in Q4 2024 for HeartSciences, down from $207592.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $232868.0 in Q2 2022 to a low of $32103.0 in Q4 2024.
  • Median Other Non-Current Liabilities over the past 3 years was $195514.0 (2023), compared with a mean of $166926.3.
  • The widest YoY moves for Other Non-Current Liabilities: up 50.46% in 2023, down 19.5% in 2023.
  • HeartSciences' Other Non-Current Liabilities stood at $137967.0 in 2022, then surged by 50.46% to $207592.0 in 2023, then tumbled by 84.54% to $32103.0 in 2024.
  • The last three reported values for Other Non-Current Liabilities were $32103.0 (Q4 2024), $207592.0 (Q3 2023), and $187450.0 (Q2 2023) per Business Quant data.